Commercial, Regulatory and Clinical Advisory Board

Trees_BG

Commercial, Regulatory and Clinical Advisory Board

Iceni™ Pharmaceuticals benefits from an expert advisory board with broad clinical and commercial expertise in multiple myeloma, bone disease and cilengitide.


Annalisa_Jenkins

Annalisa Jenkins MBBS, MRCP

Annalisa Jenkin’s previous roles include Head of Global Research & Development at Merck Serono, during which time cilengitide was one of the drug development programs. Prior to this, she held several leadership roles at Bristol Myers-Squibb (BMS) from 1997 to 2011, most recently serving as Senior VP and Head of Global Medical Affairs. Click for Bio

Horst_Kessler

Horst Kessler PhD

Prof. Dr. Horst Kessler, Carl von Linde Professor, is a Senior Fellow at the Institute for Advanced Study, Technische Universität München, Germany. Dr Kessler’s research covers the design and synthesis of peptides and peptidomimetics and their functionalization. Click for Bio

Gareth_Morgan

Gareth Morgan, MD, PhD, FRCP, FRCPath

Dr Gareth Morgan is professor of medicine and pathology and director of the Myeloma Institute for Research and Therapy at the University of Arkansas for Medical Sciences (UAMS), one of the world’s foremost myeloma treatment centres. Click for Bio

Bruno_Osterwalder

Bruno Osterwalder MD, FFPM

Dr Osterwalder is a board certified hematologist and oncologist with a background of 15 years of academic and clinical practice in internal medicine, hematology and oncology (Swiss Board Certifications). This was followed by 24 years in global drug development and strategic portfolio management in the fields of oncology and immune-oncology drug development at F. Hoffmann-La Roche (VP Clinical development (anemia)) and Merck Serono (Senior VP & Senior Strategic Adviser (Oncology)). Click for Bio

Jonathan_Kearsey

Jonathan Kearsey PhD

Preclinical Manager

Dr Kearsey has over sixteen years’ experience in drug development in the biotech sector in several life sciences companies ExonHit (France), Diatos (France), and Beta cell NV (Belgium). He is a co-founder & Director at Leads To Development, a Paris based company providing expertise in the development of therapeutic molecules. Click for Bio

Vincent_Dubois

Vincent Dubois PhD

CMC Advisor

Dr Dubois is also a co-founder & Director at Leads To Development. He has nineteen years' experience of drug development in the biopharmaceutical industry having worked for Coulter Pharmaceutical and Diatos. Click for Bio

View our Board of Directors.

Key management within Iceni Pharma.

Loading